Use of REDD1 Inhibitors to Dissociate Therapeutic and Adverse Atrophogenic Effects of Glucocorticoid Receptor Agonists

Description:

Thank you for your interest in this technology. Please see our technology brief here: https://app.in-part.com/articles/Zd8gEG1x73KW

Patent Information:
Category(s):
Therapeutic
For Information, Contact:
Felipe Araujo
Director, Blue Mountain Technologies
Icahn School of Medicine at Mount Sinai
felipe.araujo@mssm.edu
Inventors:
Joel Dudley
Irina Budunova
Gleb Baida
Keywords:
Dermatology
© 2019. All Rights Reserved. Powered by Inteum